J Korean Ophthalmol Soc.  2000 Jan;41(1):51-59.

T reatment of Myopic Astigmatism using Erodible Mask: One Year Fo l l ow-up Results

Affiliations
  • 1Department of Ophthalmology, Dongsan Medical Center, Keimyung University School of Medicine.

Abstract

After Photorefractive keratecto my[PRK]and Laser in situ keratomileusis[LASIK]for myopic astigmatism correction, we evaluated the change of myopic and astigmatic refraction and analyzed the results. Toric PRK[20 eyes]and Toric LASIK [45 eyes], total 65 eyes were performed using Toric PRK program of Summit Apex Plus and erodible mask and followed up for one year. We analyzed the change of uncorrected visual acuity, best corrected visual acuity, myopic refraction and astigmatic refraction.Mean spherical refraction had decreased from preoperative -4.36 +/-1.19D [PRK]&-8 .83 +/-2.20D[LASIK]to postoperative 12 month -0.25 +/-0.52D[PRK]&-0.21 +/-0.87D[LASIK].Cylindrical refraction had changed from preoperative -1.62 +/-1.09D[PRK]&-2.07 +/- 0.96D[LASIK]to postoperative 12 month -0.16 +/-0 .3 9 D [PRK]& 0.29 +/-0.69D[LASIK].Twelve months after Toric PRK, 64.0% of mean spherical equivalent was included within +/-0.5D and 92.0%was included within +/-1.0D.Twelve months after Toric LASIK, 57.5%of mean spherical equivalent was included within +/-0.5D and 77.5%was included within +/-1.0D.Uncorrected visual acuity was 0.7 or better in 100%of the Toric PRK group and 80.0%of the Toric LASIK group.No eyes in Toric PRK group lost two or more Snellen lines of best corrected visual acuity at postoperative 12 month, while 2 eyes[5.0%]in Toric LASIK group did. We concluded that myopic astigmatism correction using erodible mask was satisfactory.

Keyword

Astigmatism; Erodible mask; Toric LASIK; Toric PRK

MeSH Terms

Astigmatism*
Cytochrome P-450 CYP1A1*
Keratomileusis, Laser In Situ
Masks*
Visual Acuity
Cytochrome P-450 CYP1A1
Full Text Links
  • JKOS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr